A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed. This crucial advance in the fight ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

Scientists from the Ineos Oxford Institute for antimicrobial research (IOI) have developed a new screening method to tackle ...